The association between metabolic syndrome components and cognitive function in community-dwelling middle-aged and older adults: the first wave result of a cohort study

Table 4 The association between components of metabolic syndrome and cognitive function

	Cognitive impairment by MoCA-T		Cognitive impairment by AD-8
	aOR (95% CI)	p	aOR (95% CI)	p
Abdominal obesity	0.98 (0.79, 1.20)	0.81	0.68 (0.50, 0.95)	0.02
Hypertension or on drug treatment	0.97 (0.78, 1.20)	0.77	0.99 (0.72, 1.37)	0.96
Hyperglycemia or on drug treatment	0.98 (0.79, 1.22)	0.87	1.18 (0.87, 1.61)	0.29
Hypertriglyceridemia or on drug treatment	0.87 (0.68, 1.12)	0.28	1.01 (0.72, 1.41)	0.95
Low HDL-C or on drug treatment	1.01 (0.82, 1.26)	0.91	0.88 (0.64, 1.22)	0.44

Cognitive impairment was defined as MoCA-T < 24 and AD-8 ≥ 2
The statistics were performed using logistic regression models, adjusting for age, sex, education level, marital status, income status, stroke history, and scores of instrumental activities of daily living and Geriatric Depression Scale-15
Abbreviations: aOR, adjusted odds ratio; HDL-C, high-density lipoprotein cholesterol; MoCA-T, the Montreal Cognitive Assessment, Taiwanese version; AD-8, The Eight-item Informant Interview to Differentiate Aging and Dementia

ISSN: 2072-1315